GRAL – grail, inc. (US:NASDAQ)
Stock Stats
News
GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
GRAIL (NASDAQ:GRAL) had its "buy" rating reaffirmed by analysts at Guggenheim.
GRAIL Inc. - Illumina's Divested Holy Grail [Seeking Alpha]
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 [Yahoo! Finance]
GRAIL: Making Strides In Cancer Detection [Seeking Alpha]
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.